Search

Now showing items 1-1 of 1

Empagliflozin improves cardiorespiratory fitness in type 2 diabetes: Translational implications

Kumar, Naresh; Garg, Ankit; Bhatt, Deepak, L.; Sabongui, Sandra; Chaudhry, Sundeep; Arena, Ross; Verma, Subodh (NRC Research Press, 2018-11)

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to prevent heart failure and reduce cardiovascular death in patients with type 2 diabetes (T2DM) and cardiovascular disease (CVD). Whether or not SGLT2 ...